Last updated: September 7, 2022
Sponsor: Queen Elizabeth Hospital, Hong Kong
Overall Status: Active - Recruiting
Phase
4
Condition
Colon Cancer Screening
Treatment
N/AClinical Study ID
NCT04474002
PICO-PEG trial
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient who mentally capable to consent for participating the trial
- 18 - 65 years old
- Scheduled for 1st colonoscopy
- Elective outpatient colonoscopy
Exclusion
Exclusion Criteria:
- Prior colorectal or abdominal-pelvic surgery
- Inflammatory bowel disease
- Active bowel condition eg intestinal obstruction
- Gastrointestinal disorders eg active ulcer, gastric outlet obstruction, gastroparesisand hypomotility syndrome
- Recent myocardial infarction, congestive heart failure, uncontrolled hypertension
- Renal dysfunction, hepatic disease
- Patient on long term tranquilizer, anti-spasmodic, prokinetic, laxative orantidiarrhoeal agents
- Hypersensitivity to PEG or SPMC solution
- Pregnant or breastfeeding women
- Inability to give informed consent
Study Design
Total Participants: 158
Study Start date:
December 07, 2020
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
Queen Elizabeth Hospital
Kowloon,
Hong KongActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.